Consumer groups ask FTC to block Novo Holdings-Catalent deal
By Jody Godoy and Maggie Fick NEW YORK (Reuters) -U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk, from acquiring contract drug manufacturer Catalent, saying the deal threatens competition in weight loss drugs and cutting-edge gene therapies. U.S. …
Consumer groups ask FTC to block Novo Holdings-Catalent deal Read More »










